PMPierre Mondoly

Pierre Mondoly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pierre Mondoly has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Multi-Center Trained Residual Neural Network for Robust Classification of Atrial High-Rate Episodes in Remotely Monitored Pacemakers and Defibrillators

    by Lars van Krimpen, Arlene John, Anand Thiyagarajah, Tanner Carbonati, Benjamin Sacristan, Karim Benali, Antoine Da Costa, Pierre Mondoly, Rémi Chauvel, Romain Eschalier, et al.

    Remote monitoring of pacemakers and defibrillators increases patient safety but also increases clinical workload. Review of atrial high-rate episodes is particularly demanding as episodes can contain atrial tachycardia or atrial fibrillation (AT/AF), noise, or far-field oversensing (FFO). Automatic review of atrial high-rate episodes by an Artificial Intelligence (AI) model can decrease the workload of remote monitoring, provided it maintains high sensitivity for true atrial tachycardia. A residual network is trained using a center-level fourfold cross validation. The four resulting models achieved a precision of 97.2–99.4% for AT/AF, 93.1–97.7% for noise, and 75.4–94.4% for FFO, while maintaining high sensitivity 98.9–99.3% for AT/AF. The four models were combined through averaging prediction probabilities to create an ensemble model. Thresholding ensemble predictions with probability > 95% resulted in a robust ensemble model that made only two errors (<0.1%) after reviewing 3925 episodes (91.9%) of the total 4271 episodes. This shows how AI models can reliably assist in remote monitoring. Future research should be aimed at classification models for other episode types and clinical validation of AI models to assist remote monitoring of pacemakers and defibrillators.

  • Open Access

    Improving Diagnostic Yield for Analyzing Periodic Electrograms in the Remote Detection of Pacemaker Lead Issues

    by Clement Quinonero, Marc Strik, Pierre Antoine Catalan, Pierre Mondoly, Julien Laborderie, Michel Haïssaguerre, Romain Eschalier, Pierre Bordachar, Sylvain Ploux

    Remote monitoring of pacemakers decreases patient complications and reduces public health expenses. The transmission of passive real-time electrograms (EGM) has been shown to increase the diagnostic yield, but this may add to the work burden. Passive EGMs provide snapshots without adjustments, while active EGMs modify pacemaker settings temporarily to encourage sensing and pacing, potentially revealing issues such as undersensing, oversensing, or loss of capture. The added value of active EGMs compared to the passive EGM remains to be shown. The objective of this multicenter observational study is to evaluate, in a large population of patients implanted with a pacemaker capable of transmitting both passive and active periodic EGMs, the added benefit of active periodic EGMs on diagnostic yield of pacemaker-related anomalies. In a retrospective analysis of 7068 EGMs from 2733 patients, active modes detected significantly more anomalies (6.7%) than passive alone (3.3%, p < 0.001), particularly for atrial leads. However, the extended duration of active EGMs (36 s versus 12 s) was the primary contributor to improved detection rates rather than the active pacing modes themselves. Our findings suggest that focusing on longer passive EGMs may enhance diagnostic yield, reducing the need for active pacing adjustments.


  • Open Access

    T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators

    by Marc Strik, Sylvain Ploux, Romain Eschalier, Pierre Mondoly, Leslie Fontagne, F. Daniel Ramirez, Michel Haïssaguerre, Pierre Bordachar

    Background: Implantable cardioverter–defibrillators (ICDs) need to reliably detect ventricular tachycardia (VT) and ventricular fibrillation (VF) while avoiding T-wave oversensing (TWOS), which is associated with a risk of inappropriate therapies. The incidence of TWOS with endovascular ICDs appears to differ between manufacturers. Objectives: We aimed to evaluate the incidence and clinical consequences of TWOS with contemporary Medtronic and Boston Scientific ICDs. Methods: Consecutive patients implanted with a recent Medtronic or Boston Scientific ICD and remotely monitored at three French centers were included. All transmitted EGMs labelled as VF, VT, non-sustained VT (NSVT), or ventricular oversensing (Medtronic) were screened for TWOS. Results: Among 7589 transmitted episodes from 674 patients with a Boston Scientific ICD, we did not identify a single case of TWOS. Among 16,790 transmitted episodes from 1733 patients with a Medtronic ICD, we identified 60 patients (3.4%) with at least one episode of TWOS. In 46 patients, TWOS was intermittent (NSVT episodes). In the remaining 14 patients, TWOS resulted in 60 sustained episodes (completed counters). No inappropriate therapies were delivered in 12 of these patients because no therapies were programmed (in monitor zones, 11 episodes) or because therapies were inhibited by the morphology discriminator (Wavelet, 19 episodes) or by the anti-TWOS algorithm (26 episodes). Two patients received inappropriate therapies due to TWOS (0.1% of patients with Medtronic ICDs). Conclusion: On review of 24,379 transmitted episodes from 2407 patients with endovascular ICDs, we found no case of TWOS with Boston Scientific devices, whereas TWOS was not uncommon with Medtronic devices. However, the risk of inappropriate therapy with Medtronic ICDs was very low (0.1%) due to the often intermittent nature of this phenomenon, the morphology discriminator, and the anti-TWOS algorithm.


  • Open Access

    Externalized Reusable Permanent Pacemaker for Prolonged Temporary Cardiac Pacing in Critical Cardiac Care Units: An Observational Monocentric Retrospective Study

    by Maxime Beneyto, Matthieu Seguret, Marine Taranzano, Pierre Mondoly, Caroline Biendel, Anne Rollin, Fanny Bounes, Meyer Elbaz, Philippe Maury, Clément Delmas

    Introduction: The use of temporary cardiac pacing is frequent in critical care units for severe bradycardia or electrical storm, but may be associated with frequent and potentially severe complications, especially when indwelling for several days. In some cases, transient indication or ongoing contraindication for a permanent pacemaker justifies prolonged temporary pacing. In that case, the implantation of an active-fixation lead connected to an externalized pacemaker represents a valuable option to increase safety and patient comfort. Yet, evidence remains scarce. We aimed to describe the population receiving prolonged temporary cardiac pacing (PTCP) and their outcomes. Methods: We retrospectively included all consecutive patients, admitted to our hospital from 2016 to 2021, who underwent PTCP. We collected in-hospital and six-month outcomes. Results: Forty-six patients (median age of 73, 63% male) were included, and twenty-nine (63%) had prior heart disease. Indications for PTCP were found: seventeen (37%) potentially reversible high-grade conduction disorders, fourteen (30%) indications for permanent pacemaker but ongoing infection, seven (15%) cardiac implantable electronic device infections requiring extraction in pacing-dependent patients, seven (15%) severe vagal hyperreactivity in prolonged critical care hospitalizations, and one (2%) recurrent sustained ventricular tachycardia requiring overdrive pacing. The median PTCP duration was nine (5–13) days. Ten (22%) patients exhibited at least one complication during hospitalization. Twenty-six (56.5%) patients required definite device implantation (twenty-five pacemakers and one cardioverter-defibrillator) and twenty (43.5%) did not (fifteen PTCP device removal for recovery and five deaths under PTCP). At six months, two (5%) deaths and two (5%) new infections of a definite implanted device occurred, all in patients with initial active infection. Conclusion: The use of prolonged temporary cardiac pacing, with an active -fixation lead connected to an externalized pacemaker, is possible and reasonable; this would allow for the possible recovery or resolution of contraindication for definite device implantation.


  • Open Access

    Successful Reversal of Severe Tachycardia-Induced Cardiomyopathy with Cardiogenic Shock by Urgent Rhythm or Rate Control: Only Rhythm and Rate Matter

    by Kim Volle, Clément Delmas, Anne Rollin, Quentin Voglimacci-Stephanopoli, Pierre Mondoly, Eve Cariou, Franck Mandel, Hubert Delasnerie, Maxime Beneyto, Michel Galinier, et al.

    Background and objectives Severe forms of Tachycardia-induced cardiomyopathy (TIC) with cardiogenic shock are not well described so far, and efficiency of catheter ablation in this setting is unknown. Methods We retrospectively included consecutive patients admitted to the Intensive Cardiac Care Unit for acute heart failure with cardiogenic shock associated with atrial arrhythmia and managed by ablation. Result Fourteen patients were included, each with cardiogenic shock and two needing the use of extracorporeal membrane oxygenation. Successful ablation was performed in the acute setting or over the following weeks. Two patients experienced relapses of arrhythmias and were treated by new ablation procedures. At 7.5 ± 5 months follow-up, all patient were alive with stable sinus rhythm. The left ventricular Ejection Fraction dramatically improved (21 vs. 54%, p = 0.001) as well as the end-diastolic left ventricular diameter (61 vs. 51 mm, p = 0.01) and NYHA class (class IV in all vs. median 1, p = 0.002). Conclusion Restoration and maintenance of sinus rhythm in severe TIC with cardiogenic shock and atrial arrhythmias lead to a major increase or normalization of LVEF, reduction of ventricular dimensions, and improvement in functional status. Ablation is efficient in long-term maintenance of sinus rhythm and may be proposed early in refractory cases.